---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-008853"
form_type: "8-K"
ticker: null
cik: "0001138978"
company_name: "Novo Integrated Sciences, Inc."
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T10:55:01.824673+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Novo Integrated extends CEO resignation to May 31; board member Pope resigns

## Summary
- CEO Robert Mattacchione's resignation extended to no later than May 31, 2025 from prior April 30 deadline.
- Mattacchione will remain Chairman of the Board and Chairman of subsidiary Novo Healthnet Ltd after CEO departure.
- Board member Michael Pope resigned effective May 1, 2025; resignation not due to any disagreement with the company.
- No permanent CEO replacement announced; search process not disclosed in the filing.

## SEC filing metadata
- accession: 0001641172-25-008853
- form_type: 8-K
- cik: 0001138978
- company_name: Novo Integrated Sciences, Inc.
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1138978/000164117225008853/0001641172-25-008853-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1138978/000164117225008853/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-008853
- JSON: https://secwatch.observer/filing/0001641172-25-008853.json
- Plain text: https://secwatch.observer/filing/0001641172-25-008853.txt

## Key facts
- Executive change
  Robert Mattacchione resigned as Chief Executive Officer at Novo Integrated Sciences, Inc..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: On April 30, 2025, the Company and Mr. Mattacchione agreed to extend the effective date of Mr. Mattacchione's resignation to no later than May 31, 2025, in order to provide the Company the necessary time to complete an efficient transition of the Chief Executive Officer position.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1138978/000164117225008853/0001641172-25-008853-index.htm
- Executive change
  Michael Pope resigned as Director at Novo Integrated Sciences, Inc..
  - Action: resigned
  - Role: Director
  source text: Also on April 30, 2025, Michael Pope resigned as a member of the Board, effective May 1, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1138978/000164117225008853/0001641172-25-008853-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.